Our Research Program integrates artificial intelligence, neurotechnology, and clinical neuroscience to advance precision, data-driven care for complex mental health conditions. Spanning AI-driven psychopharmacology, non-invasive neurostimulation, digital and computational psychiatry, and population-level analytics, our work focuses on translating innovative interventions for treatment-resistant and comorbid psychiatric disorders. By combining rapid-acting therapeutics, emerging neuromodulation approaches, scalable digital tools, and multimodal biomarkers, AI enables personalization, continuous monitoring, and adaptive care pathways – bridging research and clinical practice through rigorous, responsible innovation.